-
1دورية أكاديمية
المؤلفون: Mackie, Ian, Mancini, Ilaria, Muia, Joshua, Kremer Hovinga, Johanna, Nair, Sukesh, Machin, Sam, Baker, Ross
المصدر: International Journal of Laboratory Hematology; Dec2020, Vol. 42 Issue 6, p685-696, 12p
مصطلحات موضوعية: AUTOANTIBODIES, COLLECTION & preservation of biological specimens, BLOOD coagulation factors, CHEMILUMINESCENCE assay, CHROMOGENIC compounds, DIFFERENTIAL diagnosis, CLINICAL pathology, ENZYME-linked immunosorbent assay, HEMATOLOGY, IMMUNOASSAY, MEDICAL protocols, PATHOLOGICAL laboratories, PROTEOLYTIC enzymes, QUALITY assurance, THROMBOTIC thrombocytopenic purpura, TIME, ACCURACY
-
2دورية أكاديمية
المؤلفون: Tiefenbacher, Stefan, Albisetti, Manuela, Baker, Peter, Kappert, Guenther, Kitchen, Steve, Kremer Hovinga, Johanna A., Pouplard, Claire, Scholz, Ute, Ternisien, Catherine, Borgvall, Carin, Vicente, Tiago, Belyanskaya, Larisa, Walter, Olaf, Oldenburg, Johannes
المصدر: Haemophilia; Jul2019, Vol. 25 Issue 4, p708-717, 10p, 3 Charts, 3 Graphs
مصطلحات موضوعية: FIELD research, BLOOD coagulation factors, COMPARATIVE studies, CHROMOGENIC compounds
الشركة/الكيان: AUGUSTINIANS
-
3دورية أكاديمية
المؤلفون: Hausammann, Stefanie, Vogel, Monique, Kremer Hovinga, Johanna A., Lacroix-Desmazes, Sebastien, Stadler, Beda M., Horn, Michael P.
المصدر: PLoS ONE; Apr2013, Vol. 8 Issue 4, p1-9, 9p
مصطلحات موضوعية: ANKYRINS, ANTIGENS, IMMUNOGLOBULINS, BLOOD coagulation factors, EPITOPES, BIOCHEMISTRY, IMMUNOPATHOLOGY, HEMATOLOGY
-
4دورية أكاديمية
المؤلفون: Jalowiec, Katarzyna A., Andres, Martin, Taleghani, Behrouz Mansouri, Musa, Albulena, Dickenmann, Martina, Angelillo-Scherrer, Anne, Rovó, Alicia, Kremer Hovinga, Johanna A.
المصدر: Journal of Medical Case Reports; 10/30/2020, Vol. 14 Issue 1, pN.PAG-N.PAG, 1p
مصطلحات موضوعية: HEMOPHILIA, PLASMA cells, BLOOD coagulation factor VIII antibodies, PLASMACYTOMA, PLASMA cell diseases, CANCER, HEMOPHILIA complications, THALIDOMIDE, MULTIPLE myeloma, BLOOD coagulation factors
-
5دورية أكاديمية
المؤلفون: Scully, M.1, Cataland, S. R.2, Peyvandi, F.3, Coppo, P.4, Knöbl, P.5, Hovinga, J. A. Kremer6, Metjian, A.7, de la Rubia, J.8, Pavenski, K.9, Callewaert, F.10, Biswas, D.10, De Winter, H.10, Zeldin, R. K.10 hilde.dewinter@ablynx.com, Scully, Marie11, Cataland, Spero R11, Peyvandi, Flora11, Coppo, Paul11, Knöbl, Paul11, Kremer Hovinga, Johanna A11, Metjian, Ara11
المصدر: New England Journal of Medicine. 1/24/2019, Vol. 380 Issue 4, p335-346. 12p.
مصطلحات موضوعية: *THERAPEUTIC use of immunoglobulins, *THROMBOTIC thrombocytopenic purpura treatment, *FIBRINOLYTIC agents, *BLOOD coagulation factors, *COMPARATIVE studies, *GINGIVAL hyperplasia, *HEMORRHAGE, *IMMUNOGLOBULINS, *RESEARCH methodology, *MEDICAL cooperation, *PLASMA exchange (Therapeutics), *RESEARCH, *THROMBOTIC thrombocytopenic purpura, *EVALUATION research, *BODY mass index, *RANDOMIZED controlled trials, *BLIND experiment, *PLATELET count, *CHEMICAL inhibitors, THERAPEUTIC use of fibrinolytic agents
-
6دورية أكاديمية
المؤلفون: Peyvandi, Flora1,2, Scully, Marie3,4, Hovinga, Johanna A. Kremer5,6, Cataland, Spero7, Knöbl, Paul8, Haifeng Wu9, Artoni, Andrea1, Westwood, John-Paul3, Taleghani, Magnus Mansouri5,6, Jilma, Bernd10, Callewaert, Filip11 filip.callewaert@ablynx.com, Ulrichts, Hans12, Duby, Christian11, Tersago, Dominique11, Kremer Hovinga, Johanna A (AUTHOR), Wu, Haifeng (AUTHOR), Mansouri Taleghani, Magnus (AUTHOR), TITAN Investigators (CORPORATE AUTHOR)
المصدر: New England Journal of Medicine. 2/11/2016, Vol. 374 Issue 6, p511-522. 12p.
مصطلحات موضوعية: *THERAPEUTIC use of immunoglobulins, *THROMBOTIC thrombocytopenic purpura treatment, *BLOOD platelet aggregation, *PLASMA exchange (Therapeutics), *TREATMENT effectiveness, *FIBRINOLYTIC agents, *BLOOD coagulation factors, *COMPARATIVE studies, *GLYCOPROTEINS, *HEMORRHAGE, *IMMUNOGLOBULINS, *RESEARCH methodology, *MEDICAL cooperation, *RESEARCH, *RESEARCH funding, *THROMBOTIC thrombocytopenic purpura, *DISEASE relapse, *EVALUATION research, *RANDOMIZED controlled trials, *DISEASE remission, *BLIND experiment, *CHEMICAL inhibitors, THERAPEUTIC use of fibrinolytic agents